These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 2676139

  • 1. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission.
    Ganem G, Kuentz M, Bernaudin F, Gharbi A, Cordonnier C, Lemerle S, Karianakis G, Vinci G, Rochant H, Lebourgeois JP.
    Cancer; 1989 Nov 01; 64(9):1796-804. PubMed ID: 2676139
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G.
    Bone Marrow Transplant; 1990 Jan 01; 5(1):7-12. PubMed ID: 2404531
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Mehta J.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):637-41. PubMed ID: 8722368
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H.
    Blood; 1991 Nov 15; 78(10):2780-4. PubMed ID: 1824271
    [Abstract] [Full Text] [Related]

  • 5. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP.
    Br J Haematol; 1998 Aug 15; 102(3):656-65. PubMed ID: 9722290
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 15; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 15; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 8. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
    Demirer T, Weaver CH, Buckner CD, Petersen FB, Bensinger WI, Sanders J, Clift RA, Lilleby K, Anasetti C, Martin P.
    J Clin Oncol; 1995 Mar 15; 13(3):596-602. PubMed ID: 7884421
    [Abstract] [Full Text] [Related]

  • 9. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
    Cahn JY, Bordigoni P, Souillet G, Pico JL, Plouvier E, Reiffers J, Benz-Lemoine E, Bergerat JP, Lutz P, Colombat P.
    Bone Marrow Transplant; 1991 Jan 15; 7(1):1-4. PubMed ID: 2043871
    [Abstract] [Full Text] [Related]

  • 10. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
    Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith BD, Flinn IW.
    Biol Blood Marrow Transplant; 2005 Feb 15; 11(2):93-100. PubMed ID: 15682069
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
    Vey N, Blaise D, Stoppa AM, Bouabdallah R, Lafage M, Sainty D, Cowen D, Viens P, Lepeu G, Blanc AP.
    Bone Marrow Transplant; 1994 Sep 15; 14(3):383-8. PubMed ID: 7994259
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.
    Troussard X, Leblond V, Kuentz M, Milpied N, Jouet JP, Cordonnier C, Leporrier M, Vernant JP.
    J Clin Oncol; 1990 May 15; 8(5):809-12. PubMed ID: 2185338
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study.
    Löwenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, de Planque M, Abels J, Sonneveld P, van der Lelie J, Goudsmit R.
    J Clin Oncol; 1990 Feb 15; 8(2):287-94. PubMed ID: 2405106
    [Abstract] [Full Text] [Related]

  • 14. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, Cesaro S, Porta F, Mazzarino I, Giorgiani G, Rondelli R, Locatelli F.
    J Clin Oncol; 1999 Jun 15; 17(6):1838-46. PubMed ID: 10561223
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13.
    Mori T, Manabe A, Tsuchida M, Hanada R, Yabe H, Ohara A, Saito T, Nakazawa S.
    Med Pediatr Oncol; 2001 Nov 15; 37(5):426-31. PubMed ID: 11745870
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 15; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 17. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL.
    Bone Marrow Transplant; 1996 May 15; 17(5):763-8. PubMed ID: 8733695
    [Abstract] [Full Text] [Related]

  • 18. Comparison of autologous and allogeneic bone marrow transplantation in children with acute leukemia.
    Ohira M, Takayama J.
    Acta Paediatr Jpn; 1991 Aug 15; 33(4):558-63. PubMed ID: 1792916
    [Abstract] [Full Text] [Related]

  • 19. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):477-83. PubMed ID: 7852109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.